Glioblastoma cancer stem cells: Role of the microenvironment and therapeutic targeting

Biochemical Pharmacology

Volumn 85, Issue 5, 2013, Pages 612-622

  Persano, Luca ^a   Rampazzo, Elena ^a   Basso, Giuseppe ^a   Viola, Giampietro ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Cancer stem cells; Glioblastoma multiforme; Hypoxia; Molecular targeting

Indexed keywords

4 DIALLYLAMINOMETHYLENE 1,3,4,7,10,11,12,13,14,15,16,17 DODECAHYDRO 6 HYDROXY 1 METHOXYMETHYL 10,13 DIMETHYL 3,7,17 TRIOXO 2 OXACYCLOPENTA[A]PHENANTHREN 11 YL ACETATE; BETA CATENIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; BONE MORPHOGENETIC PROTEIN RECEPTOR 1B; CD133 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NESTIN; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE 1; WNT PROTEIN;

CANCER STEM CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME ABERRATION; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; STROMA CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; DRUG DESIGN; GLIOBLASTOMA; HUMANS; NEOPLASTIC STEM CELLS; TUMOR MICROENVIRONMENT;

EID: 84873410837     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.10.001     Document Type: Review

References (115)

1. CBTRUS. Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2008. 2012.
2. D.N. Louis Molecular pathology of malignant gliomas Annu Rev Pathol 1 2006 97 117
3. M. Westphal, and K. Lamszus The neurobiology of gliomas: from cell biology to the development of therapeutic approaches Nat Rev Neurosci 12 2011 495 508
4. X. Castells, J.J. Acebes, C. Majos, S. Boluda, M. Julia-Sape, and A.P. Candiota Development of robust discriminant equations for assessing subtypes of glioblastoma biopsies Br J Cancer 106 2012 1816 1825
5. W.A. Freije, F.E. Castro-Vargas, Z. Fang, S. Horvath, T. Cloughesy, and L.M. Liau Gene expression profiling of gliomas strongly predicts survival Cancer Res 64 2004 6503 6510
6. C.L. Nutt, D.R. Mani, R.A. Betensky, P. Tamayo, J.G. Cairncross, and C. Ladd Gene expression-based classification of malignant gliomas correlates better with survival than histological classification Cancer Res 63 2003 1602 1607
7. H.S. Phillips, S. Kharbanda, R. Chen, W.F. Forrest, R.H. Soriano, and T.D. Wu Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis Cancer Cell 9 2006 157 173
8. K.R. Swanson, C. Bridge, J.D. Murray, and E.C. Alvord Jr. Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion J Neurol Sci 216 2003 1 10
9. K.R. Swanson, R.C. Rostomily, and E.C. Alvord Jr. A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle Br J Cancer 98 2008 113 119
10. K.R. Swanson, R.C. Rockne, J. Claridge, M.A. Chaplain, E.C. Alvord Jr., and A.R. Anderson Quantifying the role of angiogenesis in malignant progression of gliomas: in silico modeling integrates imaging and histology Cancer Res 71 2011 7366 7375
11. R. Stupp, W.P. Mason, M.J. van den Bent, M. Weller, B. Fisher, and M.J. Taphoorn Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996
12. N. Sanai, and M.S. Berger Glioma extent of resection and its impact on patient outcome Neurosurgery 62 2008 753 764 discussion 264-6
13. A. Eramo, L. Ricci-Vitiani, A. Zeuner, R. Pallini, F. Lotti, and G. Sette Chemotherapy resistance of glioblastoma stem cells Cell Death Differ 13 2006 1238 1241
14. M. Smalley, L. Piggott, and R. Clarkson Breast cancer stem cells: obstacles to therapy Cancer Lett 2012
15. A. van Rhenen, N. Feller, A. Kelder, A.H. Westra, E. Rombouts, and S. Zweegman High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival Clin Cancer Res 11 2005 6520 6527
16. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
17. P. Dalerba, R.W. Cho, and M.F. Clarke Cancer stem cells: models and concepts Annu Rev Med 58 2007 267 284
18. J.E. Visvader, and G.J. Lindeman Cancer stem cells in solid tumours: accumulating evidence and unresolved questions Nat Rev Cancer 8 2008 755 768
19. R. Chen, M.C. Nishimura, S.M. Bumbaca, S. Kharbanda, W.F. Forrest, and I.M. Kasman A hierarchy of self-renewing tumor-initiating cell types in glioblastoma Cancer Cell 17 2010 362 375
20. B.K. Garvalov, and T. Acker Cancer stem cells: a new framework for the design of tumor therapies J Mol Med (Berl) 89 2011 95 107
21. D. Bonnet, and J.E. Dick Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nat Med 3 1997 730 737
22. T.N. Ignatova, V.G. Kukekov, E.D. Laywell, O.N. Suslov, F.D. Vrionis, and D.A. Steindler Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro Glia 39 2002 193 206
23. S.K. Singh, C. Hawkins, I.D. Clarke, J.A. Squire, J. Bayani, and T. Hide Identification of human brain tumour initiating cells Nature 432 2004 396 401
24. H.D. Hemmati, I. Nakano, J.A. Lazareff, M. Masterman-Smith, D.H. Geschwind, and M. Bronner-Fraser Cancerous stem cells can arise from pediatric brain tumors Proc Natl Acad Sci U S A 100 2003 15178 15183
25. M. Venere, H.A. Fine, P.B. Dirks, and J.N. Rich Cancer stem cells in gliomas: identifying and understanding the apex cell in cancer's hierarchy Glia 59 2011 1148 1154
26. A.L. Vescovi, R. Galli, and B.A. Reynolds Brain tumour stem cells Nat Rev Cancer 6 2006 425 436
27. P.S. Eriksson, E. Perfilieva, T. Bjork-Eriksson, A.M. Alborn, C. Nordborg, and D.A. Peterson Neurogenesis in the adult human hippocampus Nat Med 4 1998 1313 1317
28. D.A. Lim, and A. Alvarez-Buylla Interaction between astrocytes and adult subventricular zone precursors stimulates neurogenesis Proc Natl Acad Sci U S A 96 1999 7526 7531
29. O. Gonzalez-Perez, and A. Alvarez-Buylla Oligodendrogenesis in the subventricular zone and the role of epidermal growth factor Brain Res Rev 67 2011 147 156
30. O. Gonzalez-Perez, F. Jauregui-Huerta, and A.Y. Galvez-Contreras Immune system modulates the function of adult neural stem cells Curr Immunol Rev 6 2010 167 173
31. R.A. Ihrie, and A. Alvarez-Buylla Lake-front property: a unique germinal niche by the lateral ventricles of the adult brain Neuron 70 2011 674 686
32. C. Calabrese, H. Poppleton, M. Kocak, T.L. Hogg, C. Fuller, and B. Hamner A perivascular niche for brain tumor stem cells Cancer Cell 11 2007 69 82
33. N. Charles, and E.C. Holland The perivascular niche microenvironment in brain tumor progression Cell Cycle 9 2010 3012 3021
34. S.A. Goldman, and Z. Chen Perivascular instruction of cell genesis and fate in the adult brain Nat Neurosci 14 2011 1382 1389
35. M. Crocker, S. Saadoun, A. Jury, C. Jones, S. Zacharoulis, and S. Thomas Glioblastoma blood flow measured with stable xenon CT indicates tumor necrosis, vascularity, and brain invasion Neuro Oncol 14 2012 641 648
36. E. Kokovay, S. Goderie, Y. Wang, S. Lotz, G. Lin, and Y. Sun Adult SVZ lineage cells home to and leave the vascular niche via differential responses to SDF1/CXCR4 signaling Cell Stem Cell 7 2010 163 173
37. Q. Shen, Y. Wang, E. Kokovay, G. Lin, S.M. Chuang, and S.K. Goderie Adult SVZ stem cells lie in a vascular niche: a quantitative analysis of niche cell-cell interactions Cell Stem Cell 3 2008 289 300
38. T.S. Zhu, M.A. Costello, C.E. Talsma, C.G. Flack, J.G. Crowley, and L.L. Hamm Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells Cancer Res 71 2011 6061 6072
39. D.B. Gursel, N. Berry, and J.A. Boockvar The contribution of Notch signaling to glioblastoma via activation of cancer stem cell self-renewal: the role of the endothelial network Neurosurgery 70 2012 N19 N21
40. P. Vaupel, A. Mayer, and M. Hockel Tumor hypoxia and malignant progression Methods Enzymol 381 2004 335 354
41. S.M. Evans, K.W. Jenkins, W.T. Jenkins, T. Dilling, K.D. Judy, and A. Schrlau Imaging and analytical methods as applied to the evaluation of vasculature and hypoxia in human brain tumors Radiat Res 170 2008 677 690
42. S.M. Evans, K.D. Judy, I. Dunphy, W.T. Jenkins, P.T. Nelson, and R. Collins Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding Cancer Res 64 2004 1886 1892
43. F. Pistollato, S. Abbadi, E. Rampazzo, L. Persano, A. Della Puppa, and C. Frasson Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma Stem Cells 28 2010 851 862
44. K. Helczynska, A. Kronblad, A. Jogi, E. Nilsson, S. Beckman, and G. Landberg Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ Cancer Res 63 2003 1441 1444
45. A. Jogi, I. Ora, H. Nilsson, A. Lindeheim, Y. Makino, and L. Poellinger Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype Proc Natl Acad Sci U S A 99 2002 7021 7026
46. J.A. Garcia HIFing the brakes: therapeutic opportunities for treatment of human malignancies Sci STKE 2006 2006 pe25
47. G.L. Wang, and G.L. Semenza Purification and characterization of hypoxia-inducible factor 1 J Biol Chem 270 1995 1230 1237
48. R.K. Bruick, and S.L. McKnight A conserved family of prolyl-4- hydroxylases that modify HIF Science 294 2001 1337 1340
49. 2-regulated prolyl hydroxylation Science 292 2001 468 472
50. M. Lopez-Lazaro HIF-1: hypoxia-inducible factor or dysoxia-inducible factor FASEB J 20 2006 828 832
51. R.H. Xu, H. Pelicano, Y. Zhou, J.S. Carew, L. Feng, and K.N. Bhalla Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia Cancer Res 65 2005 613 621
52. 2 sensing J Biol Chem 275 2000 25130 25138
53. G.L. Semenza Targeting HIF-1 for cancer therapy Nat Rev Cancer 3 2003 721 732
54. 2 sensing: only skin deep Cell 133 2008 206 208
55. F. Pistollato, H.L. Chen, B.R. Rood, H.Z. Zhang, D. D'Avella, and L. Denaro Hypoxia and HIF1alpha repress the differentiative effects of BMPs in high-grade glioma Stem Cells 27 2009 7 17
56. F. Pistollato, E. Rampazzo, S. Abbadi, A. Della Puppa, R. Scienza, and D. D'Avella Molecular mechanisms of HIF-1alpha modulation induced by oxygen tension and BMP2 in glioblastoma derived cells PLoS ONE 4 2009 e6206
57. F. Pistollato, H.L. Chen, P.H. Schwartz, G. Basso, and D.M. Panchision Oxygen tension controls the expansion of human CNS precursors and the generation of astrocytes and oligodendrocytes Mol Cell Neurosci 35 2007 424 435
58. E.E. Bar, A. Lin, V. Mahairaki, W. Matsui, and C.G. Eberhart Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres Am J Pathol 177 2010 1491 1502
59. M.V. Gustafsson, X. Zheng, T. Pereira, K. Gradin, S. Jin, and J. Lundkvist Hypoxia requires notch signaling to maintain the undifferentiated cell state Dev Cell 9 2005 617 628
60. S.G. Piccirillo, B.A. Reynolds, N. Zanetti, G. Lamorte, E. Binda, and G. Broggi Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells Nature 444 2006 761 765
61. A.M. Spence, M. Muzi, K.R. Swanson, F. O'Sullivan, J.K. Rockhill, and J.G. Rajendran Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival Clin Cancer Res 14 2008 2623 2630
62. J. Kolenda, S.S. Jensen, C. Aaberg-Jessen, K. Christensen, C. Andersen, and N. Brunner Effects of hypoxia on expression of a panel of stem cell and chemoresistance markers in glioblastoma-derived spheroids J Neurooncol 103 2011 43 58
63. S.G. Piccirillo, R. Combi, L. Cajola, A. Patrizi, S. Redaelli, and A. Bentivegna Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution Oncogene 28 2009 1807 1811
64. M. Tafani, M. Di Vito, A. Frati, L. Pellegrini, E. De Santis, and G. Sette Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma J Neuroinflammation 8 2011 32
65. S. Bao, Q. Wu, R.E. McLendon, Y. Hao, Q. Shi, and A.B. Hjelmeland Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Nature 444 2006 756 760
66. D. Beier, S. Rohrl, D.R. Pillai, S. Schwarz, L.A. Kunz-Schughart, and P. Leukel Temozolomide preferentially depletes cancer stem cells in glioblastoma Cancer Res 68 2008 5706 5715
67. V. Clement, P. Sanchez, N. de Tribolet, I. Radovanovic, and A. Ruiz i Altaba HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity Curr Biol 17 2007 165 172
68. C. Chua, N. Zaiden, K.H. Chong, S.J. See, M.C. Wong, and B.T. Ang Characterization of a side population of astrocytoma cells in response to temozolomide J Neurosurg 109 2008 856 866
69. H.L. Chen, and D.M. Panchision Concise review: bone morphogenetic protein pleiotropism in neural stem cells and their derivatives-alternative pathways, convergent signals Stem Cells 25 2007 63 68
70. S.R. Chirasani, A. Sternjak, P. Wend, S. Momma, B. Campos, and I.M. Herrmann Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cells Brain 133 2010 1961 1972
71. C.M. Tate, R. Pallini, L. Ricci-Vitiani, M. Dowless, T. Shiyanova, and G.Q. D'Alessandris A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells Cell Death Differ 2012
72. J. Lee, M.J. Son, K. Woolard, N.M. Donin, A. Li, and C.H. Cheng Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells Cancer Cell 13 2008 69 80
73. X. Liu, L. Wang, S. Zhao, X. Ji, Y. Luo, and F. Ling Beta-catenin overexpression in malignant glioma and its role in proliferation and apoptosis in glioblastma cells Med Oncol 28 2010 608 614
74. P. Pu, Z. Zhang, C. Kang, R. Jiang, Z. Jia, and G. Wang Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth Cancer Gene Ther 16 2009 351 361
75. G. Foltz, J.G. Yoon, H. Lee, L. Ma, Q. Tian, and L. Hood Epigenetic regulation of wnt pathway antagonists in human glioblastoma multiforme Genes Cancer 1 2011 81 90
76. J. Shou, F. Ali-Osman, A.S. Multani, S. Pathak, P. Fedi, and K.S. Srivenugopal Human Dkk-1, a gene encoding a Wnt antagonist, responds to DNA damage and its overexpression sensitizes brain tumor cells to apoptosis following alkylation damage of DNA Oncogene 21 2002 878 889
77. H. Zheng, H. Ying, H. Yan, A.C. Kimmelman, D.J. Hiller, and A.J. Chen p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation Nature 455 2008 1129 1133
78. A.M. Bleau, D. Hambardzumyan, T. Ozawa, E.I. Fomchenko, J.T. Huse, and C.W. Brennan PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells Cell Stem Cell 4 2009 226 235
79. D. Koul, J. Fu, R. Shen, T.A. LaFortune, S. Wang, and N. Tiao Antitumor activity of NVP-BKM120-a selective pan class I PI3 kinase inhibitor showed differential forms of cell death based on p53 status of glioma cells Clin Cancer Res 18 2012 184 195
80. D. Koul, R. Shen, Y.W. Kim, Y. Kondo, Y. Lu, and J. Bankson Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastoma Neuro Oncol 12 2010 559 569
81. C.E. Eyler, W.C. Foo, K.M. LaFiura, R.E. McLendon, A.B. Hjelmeland, and J.N. Rich Brain cancer stem cells display preferential sensitivity to Akt inhibition Stem Cells 26 2008 3027 3036
82. H. Momota, E. Nerio, and E.C. Holland Perifosine inhibits multiple signaling pathways in glial progenitors and cooperates with temozolomide to arrest cell proliferation in gliomas in vivo Cancer Res 65 2005 7429 7435
83. L. de la Pena, W.E. Burgan, D.J. Carter, M.G. Hollingshead, M. Satyamitra, and K. Camphausen Inhibition of Akt by the alkylphospholipid perifosine does not enhance the radiosensitivity of human glioma cells Mol Cancer Ther 5 2006 1504 1510
84. K.L. Pitter, C.J. Galban, S. Galban, O.S. Tehrani, F. Li, and N. Charles Perifosine and CCI 779 co-operate to induce cell death and decrease proliferation in PTEN-intact and PTEN-deficient PDGF-driven murine glioblastoma PLoS One 6 2011 e14545
85. P.Y. Wen, E.Q. Lee, D.A. Reardon, K.L. Ligon, and W.K. Alfred Yung Current clinical development of PI3K pathway inhibitors in glioblastoma Neuro Oncol 14 2012 819 829
86. W. Wick, M. Weller, M. Weiler, T. Batchelor, A.W. Yung, and M. Platten Pathway inhibition: emerging molecular targets for treating glioblastoma Neuro Oncol 13 2011 566 579
87. G.L. Gallia, B.M. Tyler, C.L. Hann, I.M. Siu, V.L. Giranda, and A.L. Vescovi Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells Mol Cancer Ther 8 2009 386 393
88. S.M. Chang, P. Wen, T. Cloughesy, H. Greenberg, D. Schiff, and C. Conrad Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme Invest New Drugs 23 2005 357 361
89. E. Galanis, J.C. Buckner, M.J. Maurer, J.I. Kreisberg, K. Ballman, and J. Boni Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study J Clin Oncol 23 2005 5294 5304
90. G. Minniti, R. Muni, G. Lanzetta, P. Marchetti, and R.M. Enrici Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents Anticancer Res 29 2009 5171 5184
91. N. Gulati, M. Karsy, L. Albert, R. Murali, and M. Jhanwar-Uniyal Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility Int J Oncol 35 2009 731 740
92. G. Prasad, T. Sottero, X. Yang, S. Mueller, C.D. James, and W.A. Weiss Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide Neuro Oncol 13 2011 384 392
93. T. Bagci-Onder, H. Wakimoto, M. Anderegg, C. Cameron, and K. Shah A dual PI3K/mTOR inhibitor, PI-103, cooperates with stem cell-delivered TRAIL in experimental glioma models Cancer Res 71 2011 154 163
94. J.S. Chen, L.J. Zhou, M. Entin-Meer, X. Yang, M. Donker, and Z.A. Knight Characterization of structurally distinct, isoform-selective phosphoinositide 3′-kinase inhibitors in combination with radiation in the treatment of glioblastoma Mol Cancer Ther 7 2008 841 850
95. M.A. Westhoff, J.A. Kandenwein, S. Karl, S.H. Vellanki, V. Braun, and A. Eramo The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair Oncogene 28 2009 3586 3596
96. Q.W. Fan, and W.A. Weiss Inhibition of PI3K-Akt-mTOR signaling in glioblastoma by mTORC1/2 inhibitors Methods Mol Biol 821 2012 349 359
97. Q.W. Fan, and W.A. Weiss Autophagy and Akt promote survival in glioma Autophagy 7 2011 536 538
98. J. Sunayama, K. Matsuda, A. Sato, K. Tachibana, K. Suzuki, and Y. Narita Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells Stem Cells 28 2010 1930 1939
99. J. Sunayama, A. Sato, K. Matsuda, K. Tachibana, E. Watanabe, and S. Seino FoxO3a functions as a key integrator of cellular signals that control glioblastoma stem-like cell differentiation and tumorigenicity Stem Cells 29 2011 1327 1337
100. G.L. Semenza Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy Trends Pharmacol Sci 33 2012 207 214
101. Y. Xia, H.K. Choi, and K. Lee Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors Eur J Med Chem 49 2012 24 40
102. S. Coma, A. Shimizu, and M. Klagsbrun Hypoxia induces tumor and endothelial cell migration in a semaphorin 3F- and VEGF-dependent manner via transcriptional repression of their common receptor neuropilin 2 Cell Adh Migr 5 2011 266 275
103. X. Zheng, Q. Xie, S. Li, and W. Zhang CXCR4-positive subset of glioma is enriched for cancer stem cells Oncol Res 19 2012 555 561
104. D. Tseng, D.A. Vasquez-Medrano, and J.M. Brown Targeting SDF-1/CXCR4 to inhibit tumour vasculature for treatment of glioblastomas Br J Cancer 104 2011 1805 1809
105. M. Kioi, H. Vogel, G. Schultz, R.M. Hoffman, G.R. Harsh, and J.M. Brown Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice J Clin Invest 120 2010 694 705
106. K. Seystahl, and M. Weller Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma Expert Opin Investig Drugs 21 2012 605 617
107. T.T. Batchelor, D.G. Duda, E. di Tomaso, M. Ancukiewicz, S.R. Plotkin, and E. Gerstner Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma J Clin Oncol 28 2010 2817 2823
108. E.R. Gerstner, P.J. Chen, P.Y. Wen, R.K. Jain, T.T. Batchelor, and G. Sorensen Infiltrative patterns of glioblastoma spread detected via diffusion MRI after treatment with cediranib Neuro Oncol 12 2010 466 472
109. M. Chahal, Y. Xu, D. Lesniak, K. Graham, K. Famulski, and J.G. Christensen MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib Neuro Oncol 12 2010 822 833
110. E. Pan, D. Yu, B. Yue, L. Potthast, S. Chowdhary, and P. Smith A prospective phase II single-institution trial of sunitinib for recurrent malignant glioma J Neurooncol 110 2012 111 118
111. B. Neyns, J. Sadones, C. Chaskis, M. Dujardin, H. Everaert, and S. Lv Phase II study of sunitinib malate in patients with recurrent high-grade glioma J Neurooncol 103 2011 491 501
112. D.A. Reardon, J.J. Vredenburgh, A. Coan, A. Desjardins, K.B. Peters, and S. Gururangan Phase I study of sunitinib and irinotecan for patients with recurrent malignant glioma J Neurooncol 105 2011 621 627
113. A. Broniscer, J.N. Baker, M. Tagen, A. Onar-Thomas, R.J. Gilbertson, and A.M. Davidoff Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma J Clin Oncol 28 2010 4762 4768
114. V. Damiano, D. Melisi, C. Bianco, D. Raben, R. Caputo, and G. Fontanini Cooperative antitumor effect of multitargeted kinase inhibitor ZD6474 and ionizing radiation in glioblastoma Clin Cancer Res 11 2005 5639 5644
115. J. Drappatz, A.D. Norden, E.T. Wong, L.M. Doherty, D.C. Lafrankie, and A. Ciampa Phase I study of vandetanib with radiotherapy and temozolomide for newly diagnosed glioblastoma Int J Radiat Oncol Biol Phys 78 2010 85 90